Drug-labels.com

Sandoz Cefprozil (Sandoz Canada, 250 mg, 500 mg): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
250 mg, 500 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Sandoz Cefprozil (Sandoz Canada, 250 mg, 500 mg)

ABOUT THIS MEDICATION

Sandoz Cefprozil is the generic brand name for a drug

called cefprozil.

What the medication is used for:

The most common uses of Sandoz Cefprozil are:

  • respiratory infections
  • urinary tract infections
  • skin infections
  • acute sinusitis

Antibacterial drugs like Sandoz Cefprozil treat only

bacterial infections. They do not treat viral infections

such as the common cold. Although you may feel better early in treatment, Sandoz Cefprozil should be used exactly as directed. Misuse or overuse of Sandoz Cefprozil could lead to the growth of bacteria that will not be killed by Sandoz Cefprozil (resistance). This means that Sandoz Cefprozil may not work for you in the future. Do not share your medicine.

For other possible uses, please speak to your doctor or

pharmacist.

What it does:

Sandoz Cefprozil is an antibiotic.

When it should not be used:

Do not use if allergic to cefprozil or any of the

nonmedicinal ingredients present in Sandoz Cefprozil (See “What the important non-medicinal ingredients are” section below).

What the medicinal ingredient is:

Sandoz Cefprozil tablets contain the active ingredient called cefprozil.

What the important nonmedicinal ingredients are:

Sandoz Cefprozil tablets contain the following nonmedicinal ingredients: hypromellose, magnesium stearate, methylcellulose, microcrystalline cellulose, polyethylene glycol, polysorbate 80, sodium starch glycolate, titanium dioxide. The 500 mg strength also contains ferric oxide yellow.

What dosage forms it comes in:

Tablets, 250 mg and 500 mg.

WARNINGS AND PRECAUTIONS

Before starting Sandoz Cefprozil and to get the best possible treatment, be sure to tell your doctor if you:

  • Are allergic to penicillins, cephalopsporins,

    cefprozil or any other drugs.

  • Do not use if you are pregnant, plan to become pregnant or are breastfeeding.

  • Do not use for children below the age of 6 months.

  • Caution is required when cefprozil is used for the chronically ill or institutionalized elderly.

INTERACTIONS WITH THIS MEDICATION

Drugs that may interact with Sandoz Cefprozil include aminoglycoside antibiotics and probenecid.

Before you use Sandoz Cefprozil talk to your doctor or pharmacist.

PROPER USE OF THIS MEDICATION

Adults (13 years and older)

Usual dose:

Respiratory and Urinary Tract Infections: 500 mg once daily.

Skin Infections: 250 mg every 12 hours or 500 mg once

daily.

Acute Sinusitis: 250 mg or 500 mg, every 12 hours.

IMPORTANT: PLEASE READ

Overdose:

Call your doctor or pharmacist right away in case of an overdose.

Missed Dose:

Call your doctor or pharmacist right away in case of a

missed dose.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

The most common side effects are diarrhea, nausea,

vomiting and abdominal pain.

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases

Severe Cutaneous Adverse Reactions (SCAR) (severe skin reactions that may also affect other organs):

  • Skin peeling, scaling, or blistering (with or without pus) which may also affect your eyes, mouth, nose or genitals, itching, severe rash, bumps under the skin, skin pain, skin color changes (redness, yellowing, purplish)
  • Swelling and redness of eyes or face
  • Flu-like feeling, fever, chills, body aches, swollen
✓
  • glands, cough
  • Shortness of breath, chest pain or discomfort

This is not a complete list of side effects. For any unexpected effects while taking Sandoz Cefprozil, contact your doctor or pharmacist.

HOW TO STORE IT

Keep out of reach and sight of children.

Sandoz Cefprozil must be stored between 15 and 30oC and protected from light and excessive humidity.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html ) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

If you want more information about Sandoz Cefprozil:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html); the manufacturer’s website (www.sandoz.ca), or by calling 1-800-361-3062.

    Or by written request at:

    110 de Lauzon

    Boucherville QC

    J4B 1E6

Or by e-mail at:

medinfo@sandoz.com

Date of Revision: October 6, 2020

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02302179

Revision date stated in the text: October 6, 2020

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Sandoz Cefprozil (Sandoz Canada, 250 mg, 500 mg)

Rx or OTC
Prescription (Rx)?
DIN 02302179, 02302187
Schedule(s) PRESCRIPTION
Active ingredient(s) Cefprozil
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. J Antiinfectives for systemic use
    1. J01 Antibacterials for systemic use
      1. J01D Other beta-lactam antibacterials
        1. J01DC Second-generation cephalosporins
          1. J01DC10 Cefprozil
Company SANDOZ CANADA INCORPORATED
Current status Cancelled Post Market
Current status date July 23, 2021
Strengths and forms
DIN Strength Dosage form(s) Current status
02302179 250 MG Tablet Cancelled Post Market July 23, 2021
02302187 500 MG Tablet Cancelled Post Market July 23, 2021

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.